SCHEMBL20122936

SCHEMBL20122936

Cc1nccc2c3cc(Cl)cc(-c4cnn(C)c4)c3n(C)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.41
AURKB Q96GD4 2/20 0.41
INCENP Q9NQS7 2/20 0.41
TPX2 Q9ULW0 2/20 0.41
MTOR P42345 1/20 0.39
PDK2 Q15119 1/20 0.39
MAOA P21397 1/20 0.38
DYRK1A Q13627 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
LRRK2 Q5S007 1/20 0.38
FGFR3 P22607 1/20 0.38
KDR P35968 1/20 0.38
TDO2 P48775 1/20 0.37
TTK P33981 3/20 0.37
BCL6 P41182 1/20 0.36
BRD4 O60885 1/20 0.35
RET P07949 3/20 0.35
PIM1 P11309 1/20 0.35
MAPK10 P53779 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30664285 0.86 DYRK1A (0.41) AURKAAURKBINCENPTPX2MTOR
SCHEMBL20122935 0.86 DYRK1A (0.41) AURKAAURKBINCENPTPX2MTOR
SCHEMBL20122972 0.79 DYRK1A (0.55) MAOADYRK1ABCHEACHE
SCHEMBL29756331 0.79 DYRK1A (0.55) MAOADYRK1ABCHEACHE
SCHEMBL20122768 0.78 AURKA (0.43) AURKAAURKBINCENPTPX2MTOR
SCHEMBL30664333 0.78 AURKA (0.43) AURKAAURKBINCENPTPX2MTOR
SCHEMBL20122851 0.76 DYRK1A (0.47) MAOADYRK1ABCHEACHE
SCHEMBL29000914 0.76 MAOA (0.52) AURKAAURKBINCENPTPX2MAOA
SCHEMBL20122904 0.74 DYRK1A (0.42) AURKAAURKBINCENPTPX2MTOR
SCHEMBL20122849 0.74 DYRK1A (0.45) MAOADYRK1ABCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2023-11-28 US disclosed
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2023-11-28 US disclosed
US-11130755-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2021-09-28 US disclosed
EP-3792262-A1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI (FR) 2021-03-17 EP disclosed
EP-3535263-B1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI SA (FR) 2020-09-30 EP disclosed
EP-3535263-A1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS Sanofi (FR) 2019-09-11 EP disclosed
EP-3318563-A1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI (FR) 2018-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders COL2A1, IDO1, COL1A1 AURKA 1279/4885AURKB 461/4885INCENP 3517/4885
US-11130755-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders COL2A1, IDO1, COL1A1 AURKA 1279/4885AURKB 461/4885INCENP 3517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.